By: Benzinga
Acorda Therapeutics Could Be a Stock to Watch in 2013
Acorda Therapeutics (NASDAQ: ACOR ) has been off to a hot start in 2013. The stock is already up around 16 percent on the year and shares are trading near 52-week high levels at roughly $29. The company has a market cap of $1.16 billion at current levels and
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here